Macquarie Group LTD Icu Medical Inc Transaction History

Macquarie Group LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$149.44 - $188.1 $70,535 - $88,783	-472 Reduced 59.0%	328 $98,000
Q2 2022 Aug 15, 2022	BUY	$161.4 - $229.7 $24,532 - $34,914	152 Added 23.46%	800 $132,000
Q4 2021 Feb 11, 2022	SELL	$220.96 - $247.44 $19,223 - $21,527	-87 Reduced 11.84%	648 $154,000
Q1 2021 May 14, 2021	SELL	$197.58 - $222.54 $38,132 - $42,950	-193 Reduced 20.8%	735 $151,000
Q2 2020 Aug 11, 2020	BUY	$172.31 - $230.89 $56,517 - $75,731	328 Added 54.67%	928 $171,000
Q4 2019 Feb 14, 2020	BUY	$151.88 - $189.51 $91,128 - $113,706	600 New	600 $112,000
Q1 2019 May 15, 2019	SELL	$221.09 - $253.28 $22,109 - $25,328	-100 Closed	0 $0
Q4 2018 Feb 15, 2019	SELL	$213.13 - $281.01 $42,626 - $56,202	-200 Reduced 66.67%	100 $23,000
Q3 2018 Nov 15, 2018	SELL	$265.5 - $307.63 $292,050 - $338,393	-1,100 Reduced 78.57%	300 $85,000
Q2 2018 Aug 14, 2018	BUY	$245.65 - $309.75 $343,910 - $433,650	1,400 New	1,400 $411,000

276

24.1M

28.3K

35.5K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $4.19B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.